Abiopharma

🔍 Jones David S. (Director)

Company: SHORE BANCSHARES INC (SHBI)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 2,310 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,960.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 1,241.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By Company Southern Drywell, Inc. | shares_owned_after: 37,192.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By Company Jones of Annapolis, Inc. | shares_owned_after: 9,279.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By LLC Sonne Capital | shares_owned_after: 10,315.00
• Sold 2,310 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,855.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F4

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Each restricted stock unit represents a contingent right to receive one share of SHBI common stock.
• F3: These restricted stock units vested on July 29, 2026.
• F4: The restricted stock units vest as follows: 1,855 units on May 21, 2027.